We’re excited to announce that Dr Kevin Cross, Director of Insilico Science and Business Development, will be speaking at GTA 2026!
His presentation, “EMA Mutamind Study and Prediction of Nitrosamine Metabolism,” will feature in the “Nitrosamine Safety Assessment” symposium on Thursday 7 May.
For more information, visit the Event Website
